Identification of natural antigenic peptides of a human gastric signet ring cell carcinoma recognized by HLA-A31-restricted cytotoxic T lymphocytes

Journal of Immunology

Volumn 163, Issue 5, 1999, Pages 2783-2791

  Suzuki, Kazuhiro ^a   Sahara, Hiroeki ^a   Okada, Yohjiro ^a   Yasoshima, Takahiro ^a   Hirohashi, Yoshihiko ^a,b   Nabeta, Yuki ^a   Hirai, Itaru ^a   Torigoe, Toshihiko ^a   Takahashi, Shuji ^a   Matsuura, Akihiro ^a   Takahashi, Nobuaki ^a   Sasaki, Aya ^a   Suzuki, Manabu ^c   Hamuro, Junji ^c   Ikeda, Hideyuki ^d   Wada, Yoshimasa ^a   Hirata, Koichi ^a   Kikuchi, Kokichi ^a,e   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c AJINOMOTO CO INC   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Sapporo Immunodiagnostic Laboratory   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; PEPTIDE; PEPTIDE F4.2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIGNET RING CARCINOMA; STOMACH CARCINOMA; TUMOR IMMUNOLOGY;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; BASE SEQUENCE; CARCINOMA, SIGNET RING CELL; CLONE CELLS; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HLA-A ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TRIFLUOROACETIC ACID; TUMOR CELLS, CULTURED;

EID: 0033198186     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Sato, T., N. Sato, S. Takahashi, H. Koshiba, and K. Kikuchi. 1986. Specific cytotoxicity of a long-term cultured T cell clone on human autologous mammary cancer cells. Cancer Res. 46:4384.
2. Sato, N., Y. Wada, H. Ikeda, S. Takahashi, N. Tsuboi, A. Kishi, K. Hirata, and K. Kikuchi. 1993. Role of tumor-associated antigens in induction of specific killing by cytotoxic T lymphocytes in human autologous cancers. Gann Monogr. Cancer Res. 40:107.
3. Ueda, D., N. Sato, A. Matsuura, A. Sasaki, H. Ikeda, Y. Wada, and K. Kikuchi. 1995. T cell receptor gene structures of HLA-A26-restricted cytotoxic T lymphocyte lines against human autologous pancreatic adenocarcinoma. Jpn. J. Cancer Res. 86:691.
4. Ioannides, C. G., R. S. Freedman, C. D. Platsoucas, S. Rashed, and Y. P. Kim. 1991. Cytotoxic T cell clone isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells. J. Immunol. 146:1700.
5. Crowley, N. J., T. L. Darrow, M. A. Quinn-Allen, and H. F. Seigler. 1991. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. J. Immunol. 146:1692.
6. Coulie, P. G., F. Lehmann, B. Lethe, J. Herman, C. Lurquin, M. Andrawiss, and T. Boon. 1995. A mutated intron sequence codes for an antigenic peptide recognized by cytotoxic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA 92:7976.
7. Lehmann, F., M. Marchand, P. Hainaut, P. Pouillart, X. Saste, H. Ikeda, T. Boon, and P. Coulie. 1995. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol. 25:340.
8. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. van den Eyde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643.
9. Gaugler, B., B. van den Eynde, P. van der Bruggen, P. Romero, J. J. Gaforio, E. De Plaen, B. Lethe, F. Brasseur, and T. Boon. 1994. Human gene MAGE3 codes for an antigen recognized on a melanoma by autologous cytotoxic T lymphocytes. J. Exp. Med. 179:921.
10. Smet, C. D., C. Lurquin, P. van der Bruggen, E. De. Plaen, E. Brasseur, and T. Boon. 1994. Sequence and expression pattern of the human MAGE2 gene. Immunogenetics 39:121.
11. Kawakami, Y., S. Eliyahu, C. H. Delgado, P. F. Robbins, L. Rivoltini, S. L. Topalian, T. Miki, and S. A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91:3515.
12. Coulie, P. G., V. Brichard, A. V. Pel, T. Wöfel, J. Schneider, C. Traversari, S. Mattei, E. D. Plaen, C. Lurquin, J. P. Szikora, et al. 1994. A new gene coding for a differentiation antigen recognized by autologous cytotoxic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:35.
13. Cox, A. L., J. Skipper, Y. Chen, R. A. Henderson, T. L. Darrow, J. Shabanowitz, V. H. Engelhard, D. F. Hunt, and C. L. Slingluff, Jr. 1994. Odentification of a peptide recognized by five melanoma specific human cytotoxic T cell lines. Science 264:716.
14. Kawakami, Y., S. Eliyahu, C. H. Delgado, P. F. Robbins, K. Sakaguchi, E. Appella, J. R. Yannelli, G. J. Adema, T. Miki, and S. A. Rosenberg. 1994. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA 91:6458.
15. Marchand, M., P. Weynants, E. Rankin, F. Arienti, F. Belli, G. Parmiani, N. Cascinelli, A. Bourlond, R. Vanwijck, Y. Humblet, et al. 1995. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer 63:883.
16. Rosenberg, S. A., J. C. Yang, D. J. Schwartzentruber, P. Hwu, F. M. Marincola, S. J. Topalian, N. P. Restifo, M. E. Dadley, S. L. Schwarz, P. J. Spiess, et al. 1998. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomas. Nat. Med. 4:321.
17. Nestle, F. O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4:328.
18. Marchand, M., N. van Baren, P. Weynants, V. Brichard, B. Dreno, M. H. Tessier, E. Rankin, G. Parmiani, F. Arienti, Y. Humblet, et al. 1999. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int. J. Cancer 80:219.
19. Schichijo, S., M. Nakao, Y. Imai, H. Takasu, M. Kawamoto, F. Niiya, D. Yang, Y. Toh, H. Yamanaka, and K. Itoh. 1998. A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes. J. Exp. Med. 187:277.
20. Gaudin, C., F. Kremer, E. Angevin, V. Scott, and F. Triebel. 1999. A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma. J. Immunol. 162:1730.
21. Wada, Y., H. Ikeda, D. Ueda, M. Ohta, S. Takahashi, K. Hirata, N. Sato, and K. Kikuchi. 1992. In vitro proliferation and the cytotoxic specificity of a cryopreserved cytotoxic T cell clone reacting against human autologous tumor cells. J. Immunol. Methods 154:235.
22. Yasoshima, T., N. Sato, K. Hirata, and K. Kikuchi. 1995. The mechanism of human autologous gastric signet ring cell tumor rejection by cytotoxic T lymphocytes in the possible context of HLA-A31 molecule. Cancer 75:1484.
23. Ikeda, H., N. Sato, A. Matsuura, and K. Kikuchi. 1993. Analysis of T-cell receptor gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas. Cancer Res. 53:3078.
24. Ikeda, H., N. Sato, A. Matsuura, A. Sasaki, S. Takahashi, D. Kozutsumi, T. Kobata, K. Okumura, Y. Wada, K. Hirata, and K. Kikuchi. 1996. Clonal dominance of human autologous cytotoxic T lymphocytes against gastric carcinoma: molecular stability of the CDR3 structure of the TCRαβ gene. Int. Immunol. 8:75.
25. Ennis, P. D., J. Zemmour, R. D. Salter, and P. Parham. 1990. Rapid cloning of HLA-A, B cDNA by using the polymerase chain reaction: Frequency and nature of errors produced in amplification. Proc. Natl. Acad. Sci. USA 87:2833.
26. Arnett, K. L., E. J. Adams, and P. Parham. 1996. On the sequence of A*3101. Tissue Antigens 47:428.
27. Lin, A. Y., B. Devaux, A. Green, C. Sagerström, J. F. Elliott, and M. M. Davis. 1990. Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science 249:677.
28. Tamura, Y., N. Tsuboi, N. Sato, and K. Kikuchi. 1993. 70 kDa heat shock cognate protein is a transformation-associated antigen and a possible target for the host's anti-tumor immunity. J. Immunol. 151:5516.
29. Falk, K., O. Rötzschke, S. Stevanovic, G. Jung, H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
30. York, I. A., and K. L. Rock. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369.
31. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99.
32. Anderson, K., P. Cresswell, M. Gammon, J. Hermes, A. Williamson, and H. Zweerink. 1991. Endogeneously synthesized peptide with an endoplasmic reticulum signal sequence sentisitzes antigen processing mutant cells to class I-restricted cell-mediated lysis. J. Exp. Med. 174:489.
33. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titer retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587.
34. Moritani, M., K. Yoshimoto, S. Li, M. Kondo, H. Iwahana, T. Yamaoka, T. Sano, N. Nakano, H. Kikutani, and M. Itakura. 1996. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. J. Clin. Invest. 98:1851.
35. Tsai, V., S. Southwood, J. Sidney, K. Sakaguchi, Y. Kawakami, E. Appella, A. Sette, and E. Celis. 1997. Identification of subdominant CTL epitope of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. J. Immunol. 158:1796.
36. Falk, K., O. Rötzschke, M. Takiguchi, B. Grahovac, V. Gnau, S. Stevanovic, G. Jung, and H. G. Rammennsee. 1994. Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules. Immunogenetics 40:238.
37. Rammensee, H. G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motif: first listing. Immunogenetics 41:178.
38. + T-cell lines. Cancer Res. 55:5648.
39. Missale, G., A. Redeker, J. Person, P. Fowler. S. Guihot, H. J. Schlicht, G. Ferrari, and F. V. Chisari. 1993. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med. 177:751.
40. Pardoll, D. W. 1994. A new look for the 1990s. Nature 369:357.
41. Nanda, N. K., and E. Sercarz. 1995. Induction of anti-self-immunity to cure cancer. Cell 82:13.
42. Rivoltini, L., K. C. Barracchini, V. Viggiano, Y. Kawakami, A. Smith, A. Mixon, N. P. Restifo, S. L. Topalian, T. B. Simonis, S. A. Rosenberg, and F. M. Marincola. 1995. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res. 55:3149.
43. Van den Eynde, B., and O. van der Bruggen. 1997. T cell-defined tumor antigens. Curr. Opin. Immunol. 9:684.
44. Rosenberg, S. A., and D. E. White. 1996. Vitiligo in patients with melanoma: normal tissue antigens can be target for cancer immunotherapy. J. Immunother. 19:81.
45. Ruiz-Cabello, F., and F. Garrido. 1998. HLA and cancer: from research to clinical impact. Immunol. Today 19:539.
46. Kang, X., Kawakami, Y., M. El-Gamil, R. Wang, K. Sakaguchi, J. R. Yannelli, E. Appella, S. A. Rosenberg, and P. F. Robbins. 1995. Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J. Immunol. 155:1343.
47. V. Brichard, A. van Pel, T. Wölfel, C. Wölfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytotoxic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489.
48. Ikeda, H., B. Lethe, F. Lehmann, N. Van Baren, J. F. Baurain, C. D. Smet, H. Chambost, M. Vitale, A. Moretta, T. Boon, and P. G. Coulie. 1997. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6:199.
49. Coulie, P.G. 1997. Human Tumour antigens recognized by T cells: new perspectives for anti-cancer vaccines? Mol. Med Today 3:261.
50. Rosenberg, S. A. 1997. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol. Today 18:175.